Dr Reddys bags USFDA nod for VeraRing
Hyderabad: Drugmaker, Dr Reddy's Labs, has recently announced that the company has received approval from the U.S. Food and Drug Administration (USFDA) for ANDA 207577 (VeraRing).
An abbreviated new drug application (ANDA) contains data which is submitted to FDA for the review and potential approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.
Read also: Dr Reddy's Labs unveils Venlafaxine ER tablets in US
Dr. Reddy's Laboratories Ltd. is an integrated pharmaceutical company headquartered in Hyderabad, Telangana, India. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology.
Dr. Reddy's operates in markets across the globe. The company's major markets include - USA, India, Russia & CIS countries, and Europe.
